What's breaking now, across thousands of outlets.
In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity and pain for patients with metastatic prostate cancer.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
CVS Health is splitting into two publicly traded companies as the healthcare giant fights rising costs, retail competition, regulatory scrutiny and other pressures.
In the months leading up to the Treasury Department's release of draft rules that would limit US investment in Chinese biopharma, the industry's view of China was already in a downward sentiment ...
Historical data suggests the sector outperforms after midterm elections. And Democrats, newly in control of Congress, have “bigger fish to fry” than drug pricing, analysts said.
Lidl recalled 1,122 units after a product test returned positive for Listeria monocytogenes.
Samuel Chukwueze has undergone a successful surgery to repair a ruptured tendon of the tensor fasciae latae muscle in his left hip.
The breakup, which will separate Aetna and Caremark from CVS’ retail pharmacies, is an indictment of the dogma that bigger is always better in the healthcare industry.
